☰

cached image

William F. Hoffman, M.D., Ph.D. - Publications

Affiliations: 
Psychiatry Oregon Health and Science University, Portland, OR 
Area:
methamphetamine, cognition, decision-making
Website:
http://www.ohsu.edu/xd/education/schools/school-of-medicine/academic-programs/graduate-studies/faculty/grad-studies-faculty.cfm?facultyid=431
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Huckans M, Boyd S, Moncrief G, Hantke N, Winters B, Shirley K, Sano E, McCready H, Dennis L, Kohno M, Hoffman W, Loftis JM. Cognition during active methamphetamine use versus remission. Journal of Clinical and Experimental Neuropsychology. 1-12. PMID 34612792 DOI: 10.1080/13803395.2021.1976734  0.469
2021 Kohno M, Dennis LE, McCready H, Hoffman WF. Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment. Molecular Psychiatry. PMID 34117366 DOI: 10.1038/s41380-021-01180-4  0.492
2020 Hoffman WF, Jacobs MB, Dennis LE, McCready HD, Hickok AW, Smith SB, Kohno M. Psychopathy and Corticostriatal Connectivity: The Link to Criminal Behavior in Methamphetamine Dependence. Frontiers in Psychiatry. 11: 90. PMID 32180738 DOI: 10.3389/Fpsyt.2020.00090  0.534
2019 Dennis LE, Kohno M, McCready HD, Schwartz DL, Schwartz B, Lahna D, Nagel BJ, Mitchell SH, Hoffman WF. Correction to: Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder. Psychopharmacology. PMID 31863122 DOI: 10.1007/S00213-019-05440-8  0.52
2019 Dennis LE, Kohno M, McCready HD, Schwartz DL, Schwartz B, Lahna D, Nagel BJ, Mitchell SH, Hoffman WF. Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder. Psychopharmacology. PMID 31673722 DOI: 10.1007/S00213-019-05364-3  0.537
2019 Kohno M, Morales AM, Dennis LE, McCready H, Hoffman WF, Korthuis PT. Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder. Frontiers in Psychiatry. 10: 603. PMID 31551824 DOI: 10.3389/Fpsyt.2019.00603  0.548
2019 Kohno M, Link J, Dennis LE, McCready H, Huckans M, Hoffman WF, Loftis JM. Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacology, Biochemistry, and Behavior. PMID 30695700 DOI: 10.1016/J.Pbb.2019.01.007  0.536
2018 McCready H, Kohno M, Kolessar M, Dennis L, Kriz D, Luber H, Anderson R, Chang M, Sasaki A, Flora K, Vandenbark A, Mitchell SH, Loftis JM, Hoffman WF, Huckans M. Functional MRI and delay discounting in patients infected with hepatitis C. Journal of Neurovirology. PMID 30298201 DOI: 10.1007/S13365-018-0670-0  0.503
2018 Kohno M, Dennis LE, McCready H, Schwartz DL, Hoffman WF, Korthuis PT. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder. Drug and Alcohol Dependence. 192: 186-192. PMID 30266003 DOI: 10.1016/J.Drugalcdep.2018.07.045  0.547
2018 Kohno M, Loftis JM, Huckans M, Dennis LE, McCready H, Hoffman WF. The relationship between interleukin-6 and functional connectivity in methamphetamine users. Neuroscience Letters. PMID 29689344 DOI: 10.1016/J.Neulet.2018.04.037  0.515
2017 Kohno M, Dennis LE, McCready H, Hoffman WF. Executive Control and Striatal Resting-State Network Interact with Risk Factors to Influence Treatment Outcomes in Alcohol-Use Disorder. Frontiers in Psychiatry. 8: 182. PMID 28993741 DOI: 10.3389/Fpsyt.2017.00182  0.55
2011 Huckans M, Seelye A, Woodhouse J, Parcel T, Mull L, Schwartz D, Mitchell A, Lahna D, Johnson A, Loftis J, Woods SP, Mitchell SH, Hoffman W. Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. Journal of Clinical and Experimental Neuropsychology. 33: 176-86. PMID 20694872 DOI: 10.1080/13803395.2010.499355  0.326
2010 Schwartz DL, Mitchell AD, Lahna DL, Luber HS, Huckans MS, Mitchell SH, Hoffman WF. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage. 50: 1392-401. PMID 20096794 DOI: 10.1016/J.Neuroimage.2010.01.056  0.323
2008 Hoffman WF, Schwartz DL, Huckans MS, McFarland BH, Meiri G, Stevens AA, Mitchell SH. Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology. 201: 183-93. PMID 18685833 DOI: 10.1007/S00213-008-1261-1  0.311
2006 Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology. 188: 162-70. PMID 16915378 DOI: 10.1007/S00213-006-0494-0  0.34
1993 Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Archives of Internal Medicine. 153: 1469-75. PMID 8512437 DOI: 10.1001/Archinte.1993.00410120051007  0.333
1987 Hoffman WF, Labs SM, Casey DE. Neuroleptic-induced parkinsonism in older schizophrenics. Biological Psychiatry. 22: 427-39. PMID 2882787 DOI: 10.1016/0006-3223(87)90165-X  0.31
Show low-probability matches.